Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Leland N. Benson"'
Autor:
Ada C. Stefanescu Schmidt, Lusine Abrahamyan, Annamalar Muthuppalaniappan, Ricardo Gorocica Romero, Georges Ephrem, Karl Everett, Douglas S. Lee, Mark Osten, Leland N. Benson, Eric M. Horlick
Publikováno v:
JACC: Advances. 2:100257
Autor:
Rachel M. Wald, Leland N. Benson, Kate Hanneman, Rafael Alonso-Gonzalez, Osami Honjo, Shi-Joon Yoo, Ashish H. Shah, Erwin Oechslin, Pradeepkumar Charla, John Granton, Kenichiro Yamamura, Gauri R. Karur, Luc Mertens
Publikováno v:
Heart
ObjectivesAlthough a life-preserving surgery for children with single ventricle physiology, the Fontan palliation is associated with striking morbidity and mortality with advancing age. Our primary objective was to evaluate the impact of non-invasive
Autor:
Guido Pieles, Chun-Po Steve Fan, Seema Mital, Mark K. Friedberg, Leland N. Benson, Cedric Manlhiot, Jaime Alkon, Caroline Kinnear
Publikováno v:
Pediatric Research. 89:628-635
Background Information on genetic etiology of pediatric hypertrophic cardiomyopathy (HCM) rarely aids in risk stratification and prediction of disease onset. Little data exist on the association between genetic modifiers and phenotypic expression of
Autor:
Seema Mital, Leland N. Benson, Kristen George, Myriam Lafreniere-Roula, Yoav Bolkier, Jacob Mathew, Laura Zahavich, Cedric Manlhiot, Elizabeth A. Stephenson, Judith Wilson
Publikováno v:
European Heart Journal
Aims Current guidelines recommend initiating family screening for hypertrophic cardiomyopathy (HCM) after age 10 or 12 years unless early screening criteria are met. The aim was to evaluate if current screening guidelines miss early onset disease. Me
Autor:
G. Manase, Kristen George, A.C. Ouellette, Seema Mital, Ashok Kumar Manickaraj, Jacob Mathew, Judith Wilson, Sarah Bowdin, Leland N. Benson, Laura Zahavich
Publikováno v:
Clinical Genetics. 93:33-40
Background For clinical genetic testing of cardiomyopathy (CMP), current guidelines do not address which gene panels to use: targeted panels specific to a CMP phenotype or expanded (panCMP) panels that include genes associated with multiple phenotypi
Autor:
Myriam Lafreniere-Roula, Kristen George, Seema Mital, Leland N. Benson, Laura Zahavich, Sarah Bowdin, Jacob Mathew, Judith Wilson
Publikováno v:
Clinical genetics. 93(2)
Children with hypertrophic cardiomyopathy (HCM) experience sudden cardiac death (SCD) and other life-threatening events. We assessed if affected gene and variant burden predict outcomes. Patients18 years old with primary HCM with a pathogenic variant
Autor:
Lars Grosse-Wortmann, Leland N. Benson, John G. Coles, Andrew N. Redington, Shi-Joon Yoo, Christopher K. Macgowan, Hyun Woo Goo, Abdulmajeed Al-Otay
Publikováno v:
Journal of the American College of Cardiology. 49:993-1002
Pulmonary vein pathologies often present a diagnostic challenge. Among the different imaging modalities used for the evaluation of pulmonary veins, magnetic resonance is the most comprehensive in assessing anatomy and pathophysiology at the same time
Publikováno v:
Progress in Pediatric Cardiology. 22:161-164
Background The impact on cardiopulmonary function after endovascular stenting of an aortic arch obstruction is not well defined. We sought to determine in children following stenting whether they had normal cardiopulmonary responses to exercise and 2
Autor:
Lynne E Nield, Jeffrey F Smallhorn, Leland N Benson, Lisa K Hornberger, Earl D Silverman, Glenn P Taylor, M Mullen, J Brendan, Lisa K. Hornberger
Publikováno v:
Journal of the American College of Cardiology. 40:796-802
Objectives This study was designed to document the association of endocardial fibroelastosis (EFE) and maternal autoantibodies. Background Neonatal lupus erythematosus is associated with the transplacental passage of maternal anti-Ro and anti-La anti
Autor:
Leland N. Benson, Samuel Siu, Vanessa Razack, Fiona Walker, Peter R. McLaughlin, Hassan El-Hajj, Gruschen Veldtman, Gary D. Webb
Publikováno v:
Journal of the American College of Cardiology. 37(8):2108-2113
OBJECTIVES We sought to assess the right heart’s response to percutaneous device closure of moderate sized atrial septal defects (ASDs) in adults over a one-year follow-up period. BACKGROUND Percutaneous ASD device closure is a safe and effective m